| Items 101 ~ 120 of 26020, Page 6 of 1301 |
| 101. |
Explore Your Family Cancer History - 06/13/2019
American Cancer Society |
| |
Protect your health by learning more about your family¡¯s history of cancer and other health problems. Then find out what you can do to help lower your risk. Get the tips. |
| 102. |
New Survey Shows Millennials Can Help Avoid Blood Shortages - 06/13/2019
Abbott |
| |
45% of blood donations have historically come from people over 50 years old, but that number is declining / As more millennials bring their passion to blood donation, they can fill the gap left by aging baby boomers |
| 103. |
FDA Approves Polivy (Polatuzumab Vedotin-piiq) for Lymphoma - 06/12/2019
American Cancer Society |
| |
The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL). |
| 104. |
AAOS Member Michael Suk, MD, Elected to AMA Board of Trustees - 06/12/2019
American Academy of Orthopaedic Surgeons |
| 105. |
Population of US Cancer Survivors Grows to Nearly 17 Million - 06/11/2019
American Cancer Society |
| |
A new report by the American Cancer Society ? in collaboration with the National Cancer Institute ? estimates there are more than 16.9 million cancer survivors alive in the US today, and that number will grow to more than 22.1 million by 2030. |
| 106. |
FDA Approves Two New Indications for Merck¡¯s KEYTRUDA¢ç (pembrolizumab) - 06/11/2019
MERCK |
| |
KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Monotherapy for Patients Whose Tumors Express PD-L1 (CPS ¡Ã1) or in Combination with Platinum and Fluorouracil (FU) Regardless of PD-L1 Expression |
| 107. |
New Survey Highlights Growing Insurance Problem That Delays Sight-Saving Care - 06/11/2019
American Academy of Ophthalmology |
| |
Real-world data shows why new legislation introduced last week is needed to protect patients from unreasonable Medicare Advantage plan requirements |
| 108. |
Collaboration between France and WHO to Realize the Vision of the WHO Academy - 06/11/2019
WHO |
| 109. |
Orthopaedic PAC Endorses AAOS Member Manny Sethi, MD, for U.S. Senate - 06/11/2019
American Academy of Orthopaedic Surgeons |
| 110. |
Mental and Physical Health Drive Employee Productivity - 06/10/2019
American College of Occupational and Environmental Medicine (ACOEM) |
| |
Mental and physical health are the most important factors affecting workplace productivity, reports an open-access paper in the June Journal of Occupational and Environmental Medicine. |
| 111. |
Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes - 06/10/2019
Medtronic |
| |
ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance |
| 112. |
Merck to Acquire Tilos Therapeutics - 06/10/2019
MERCK |
| |
Merck Gains Portfolio of Investigational Antibodies Modulating TGF¥â |
| 113. |
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ - 06/10/2019
Medtronic |
| |
Four Year Partnership Made Public Today |
| 114. |
Cancer Screening Rates Linked to Time of Medical Appointment - 05/17/2019
American Cancer Society |
| |
Researchers from the University of Pennsylvania say when patients see their doctor may affect whether they are told to get screened for cancer, and the likelihood of patients to have them done. |
| 115. |
Too many babies are born too small - 05/16/2019
WHO |
| |
Around one in seven of all babies worldwide are born with a low birthweight |
| 116. |
Merck to Present New Analyses for JANUVIA¢ç (sitagliptin) and STEGLATRO¢â (ertugliflozin), and Real-World Data Studies at the 79th Scientific Sessions of the American Diabetes Association - 05/16/2019
MERCK |
| |
Real-World Evidence Research to Explore Socioeconomic, Racial and Ethnic Disparities in Diabetes Treatment |
| 117. |
Do These Seven Things Today, to Save Your Sight Tomorrow - 05/16/2019
American Academy of Ophthalmology |
| |
The American Academy of Ophthalmology urges young adults to protect their eyes to prevent vision loss in the future |
| 118. |
New ZonePerfect¢ç Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results - 05/16/2019
Abbott |
| |
Abbott's ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient ("macros") ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat / ZonePerfect Keto helps fulfill a keto lifestyle on the go - offering the only true keto ready-to-drink option available nationwide at major retailers |
| 119. |
Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases - 05/16/2019
Medtronic |
| |
FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons |
| 120. |
New Research from Merck¡¯s Broad Oncology Clinical Development Program to be Presented at 2019 ASCO Annual Meeting - 05/15/2019
MERCK |
| |
First-Time Data from POLO Trial Evaluating LYNPARZA ¢ç (olaparib) in Germline BRCA-Mutated Metastatic Pancreatic Cancer in Plenary Session and ASCO Press Program / KEYTRUDA ¢ç (pembrolizumab) Five-Year Survival Data in Advanced Non-Small Cell Lung Cancer (NSCLC) from KEYNOTE-001 Trial in ASCO Press Program / Overall Survival Data for KEYTRUDA in Metastatic Renal Cell Carcinoma (RCC), Recurrent/Metastatic Head and Neck Cancer and Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer |
